ILMN | Illumina, Inc. |
Laboratory Analytical Instruments |
Book value per $ invested | $ 0.10 |
Leverage | 64.67% |
Market Cap | $ 21.5B |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -1.6B |
Margin | -39.16% |
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.